COVID-19 БИЛАН ОҒРИГАН БЕМОРЛАРДА ДИАБЕТИК РЕТИНОПАТИЯНИНГ АЛОҚАДОРЛИГИ ВА КЛИНИК ҲУСУСИЯЛАРИ
##article.subject##:
COVID-19; диабетик ретинопатия; клиник хусусиятлари; бошқарув##article.abstract##
Ушбу мақолада бемоларда диабетик ретинопатия кечиши хусусияларини ўрганиш натижалари келтирилган. Хорижий адабиёт маълумотлари берилган. Ушбу офтальмологик касалликнинг кечиши ва коронавирус инфекцияси пандемияси шароятида диабетик ретинопатия билан оғриган беморлар билан ишлаш имкониятларини янада чуқурроқ ўрганиш муҳимлиги исботланди.
Библиографические ссылки
Abbasi K. The scandals of covid-19. Editorial. BMJ. 2020;369: m1434.
Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:766–85.
Lian JX, McGhee SM, Gangwani RA, Hedley AJ, Lam CL, Yap MK, et al. Screening for diabetic retinopathy with or without a copayment in a randomized controlled trial: influence of the inverse care law. Ophthalmology. 2013;120:1247–53. https://doi.org/10.1016/j.ophtha.2012.11.024
Gangwani RA, Lian JX, McGhee SM, Wong D, Li KK. Diabetic retinopathy screening: a global and local perspective. Hong Kong Med J. 2016;22:486–95.
Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020. https://doi.org/10.1002/jmv.25725
Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. JAMA. 2020. Doi: 10.1001/jama.2020.1097
Rosenbaum L. The Untold Toll – The Pandemic’s Effects on Patients without Covid-19. N ENgl J Med. 2020. DOI: 10.1056/ NEJMms2009984
Parrish II, RK, Stewart MW, Powers SLD. Ophthalmologists Are More Than Eye Doctors – In Memoriam Li Wenliang. Am J Ophthal. 2020. https://doi.org/10.1016/j.ajo.2020.02.014
Kulcsar MA, Montenegro FL, Arap SS, Tavares MR, Kowalsk LP. High Risk of COVID-19 Infection for Head and Neck Surgeons. Int Arch Otorhinolaryngol 2020;24(2):e129-e130.
Ben AJ, Neyeloff JL, de Souza CF et al. Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System. Appl Health Econ Health Policy. 2020;18:57-68. https:// doi.org/10.1007/s40258-019-00528-w
